Canada · Delayed Price · Currency is CAD VVT Med Statistics
Total Valuation
VVT Med has a market cap or net worth of CAD 18.07 million. The enterprise value is 18.09 million.
| Market Cap | 18.07M |
| Enterprise Value | 18.09M |
Important Dates
The next estimated earnings date is Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VVT Med has 66.93 million shares outstanding. The number of shares has increased by 5.40% in one year.
| Current Share Class | 66.93M |
| Shares Outstanding | 66.93M |
| Shares Change (YoY) | +5.40% |
| Shares Change (QoQ) | +454.16% |
| Owned by Insiders (%) | 7.62% |
| Owned by Institutions (%) | n/a |
| Float | 61.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 115.84 |
| PB Ratio | -22.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.13 |
| EV / Sales | 115.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76
| Current Ratio | 0.76 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -13,035.35% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 44.96 |
| Average Volume (20 Days) | 18,983 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VVT Med had revenue of CAD 156,004 and -4.38 million in losses. Loss per share was -0.95.
| Revenue | 156,004 |
| Gross Profit | 86,359 |
| Operating Income | -2.54M |
| Pretax Income | -4.38M |
| Net Income | -4.38M |
| EBITDA | -2.54M |
| EBIT | -2.54M |
| Loss Per Share | -0.95 |
Balance Sheet
The company has 1.57 million in cash and 1.58 million in debt, with a net cash position of -13,929 or -0.00 per share.
| Cash & Cash Equivalents | 1.57M |
| Total Debt | 1.58M |
| Net Cash | -13,929 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -802,305 |
| Book Value Per Share | -0.01 |
| Working Capital | -636,551 |
Cash Flow
| Operating Cash Flow | -3.81M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 55.36% |
| Operating Margin | -1,629.46% |
| Pretax Margin | -2,807.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VVT Med does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.40% |
| Shareholder Yield | -5.40% |
| Earnings Yield | -24.23% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 31, 2025. It was a reverse split with a ratio of 0.2141328.
| Last Split Date | Jul 31, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.2141328 |
Scores
VVT Med has an Altman Z-Score of -15.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.79 |
| Piotroski F-Score | 4 |